NCT00153946View on ClinicalTrials.gov

Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

814

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

May 31, 2008

Conditions
Stroke
Interventions
DRUG

Edaravone

30mg/20mL vial, twice per day, not longer than two weeks

Trial Locations (1)

565-8565

EAST Study Office c/o National Cardiovascular Center, Suita

Sponsors
All Listed Sponsors
collaborator

Japan Cardiovascular Research Foundation

OTHER

lead

Combination Therapy for Acute Ischemic Stroke Study Group

OTHER